Nizar Chahin

1.5k total citations
21 papers, 405 citations indexed

About

Nizar Chahin is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, Nizar Chahin has authored 21 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Nizar Chahin's work include Neurogenetic and Muscular Disorders Research (5 papers), Peripheral Neuropathies and Disorders (4 papers) and Hereditary Neurological Disorders (4 papers). Nizar Chahin is often cited by papers focused on Neurogenetic and Muscular Disorders Research (5 papers), Peripheral Neuropathies and Disorders (4 papers) and Hereditary Neurological Disorders (4 papers). Nizar Chahin collaborates with scholars based in United States and Türkiye. Nizar Chahin's co-authors include Eric J. Sorenson, Duygu Selcen, Andrew G. Engel, Christopher J. Klein, Diana Dimitrova, Chafic Karam, Chafic Karam, Amy Visser, Danilo Bernardo and Yael Shiloh‐Malawsky and has published in prestigious journals such as Blood, Neurology and Journal of the Neurological Sciences.

In The Last Decade

Nizar Chahin

20 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nizar Chahin United States 11 189 139 128 110 57 21 405
John F. Brandsema United States 12 189 1.0× 103 0.7× 125 1.0× 39 0.4× 53 0.9× 33 442
Stefan Nicolau United States 12 196 1.0× 69 0.5× 66 0.5× 95 0.9× 72 1.3× 34 365
Hacer Durmuş Türkiye 15 183 1.0× 65 0.5× 327 2.6× 84 0.8× 33 0.6× 49 594
James Miller United Kingdom 13 239 1.3× 106 0.8× 126 1.0× 150 1.4× 237 4.2× 28 573
Adolf Pou Spain 13 374 2.0× 136 1.0× 120 0.9× 89 0.8× 67 1.2× 14 638
Yiming Zheng China 13 375 2.0× 63 0.5× 78 0.6× 133 1.2× 132 2.3× 49 580
Oronzo Scarciolla Italy 10 222 1.2× 123 0.9× 54 0.4× 55 0.5× 18 0.3× 12 386
Daniel Natera‐de Benito Spain 13 214 1.1× 123 0.9× 73 0.6× 55 0.5× 16 0.3× 59 399
Cristina Cappelletti Italy 11 225 1.2× 46 0.3× 87 0.7× 49 0.4× 100 1.8× 20 494
Françoise Bouhour France 14 129 0.7× 92 0.7× 320 2.5× 162 1.5× 20 0.4× 49 533

Countries citing papers authored by Nizar Chahin

Since Specialization
Citations

This map shows the geographic impact of Nizar Chahin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nizar Chahin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nizar Chahin more than expected).

Fields of papers citing papers by Nizar Chahin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nizar Chahin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nizar Chahin. The network helps show where Nizar Chahin may publish in the future.

Co-authorship network of co-authors of Nizar Chahin

This figure shows the co-authorship network connecting the top 25 collaborators of Nizar Chahin. A scholar is included among the top collaborators of Nizar Chahin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nizar Chahin. Nizar Chahin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chahin, Nizar, Charles A. Stewart, Christopher M. Jewell, et al.. (2025). Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis. Annals of Clinical and Translational Neurology. 12(11). 2358–2366.
2.
Miljković, Miloš D., Adam S. Asch, Gregory Orloff, et al.. (2024). Safety and Tolerability of BCMA-Directed mRNA CAR T-Cell Therapy in Multiple Myeloma and Autoimmune Disease. Blood. 144(Supplement 1). 2080–2080. 1 indexed citations
3.
Medvedova, Eva, et al.. (2022). Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy – incidental or related?. Neuromuscular Disorders. 32(6). 533–538. 3 indexed citations
4.
Ensrud, Erik, et al.. (2021). CIDP mimics: a case series. BMC Neurology. 21(1). 94–94. 3 indexed citations
5.
Hansford, Barry G., et al.. (2021). Unusual cases of Anti-SRP necrotizing myopathy with predominant distal leg weakness and atrophy. Neuromuscular Disorders. 32(2). 170–175. 4 indexed citations
6.
Chahin, Nizar, et al.. (2020). IVIG Refractory CIDP: Clinical Characteristics, Antibodies, and Response to Alternative Treatment (2504). Neurology. 94(15_supplement). 1 indexed citations
7.
Karam, Chafic, et al.. (2020). Diagnosis of paraproteinemic neuropathy: Room for improvement. Journal of the Neurological Sciences. 415. 116902–116902. 5 indexed citations
8.
Chahin, Nizar, et al.. (2020). Screening for genetic mutations in patients with neuropathy without definite etiology is useful. Journal of Neurology. 267(9). 2648–2654. 12 indexed citations
9.
Barrett, Matthew J., et al.. (2020). Refractory CIDP: Clinical characteristics, antibodies and response to alternative treatment. Journal of the Neurological Sciences. 418. 117098–117098. 17 indexed citations
10.
Visser, Amy, et al.. (2020). Nusinersen in adult patients with spinal muscular atrophy. Neurology. 95(4). e413–e416. 40 indexed citations
11.
Karam, Chafic, et al.. (2019). Bright tongue sign in patients with late-onset Pompe disease. Journal of Neurology. 266(10). 2518–2523. 15 indexed citations
12.
Chahin, Nizar, et al.. (2019). Nusinersen in Adults with Spinal Muscular Atrophy, A Single Center Experience (P4.4-015). Neurology. 92(15_supplement). 1 indexed citations
13.
Haskell, Gloria, Michael C. C. Adams, Zheng Fan, et al.. (2018). Diagnostic utility of exome sequencing in the evaluation of neuromuscular disorders. Neurology Genetics. 4(1). e212–e212. 32 indexed citations
14.
Bernardo, Danilo & Nizar Chahin. (2015). Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease. Neurology Neuroimmunology & Neuroinflammation. 2(1). e63–e63. 14 indexed citations
15.
Howard, James F., et al.. (2014). Pearls & Oy-sters: Clues to the diagnosis of adult-onset acid maltase deficiency. Neurology. 82(9). e73–5. 8 indexed citations
16.
Fan, Zheng, Jiahui Wang, Mihye Ahn, et al.. (2013). Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy. Neuromuscular Disorders. 24(2). 178–191. 40 indexed citations
17.
Chahin, Nizar & Eric J. Sorenson. (2009). Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle & Nerve. 40(1). 126–129. 56 indexed citations
18.
Chahin, Nizar, et al.. (2008). Natural history of spinal-bulbar muscular atrophy. Neurology. 70(21). 1967–1971. 45 indexed citations
19.
Chahin, Nizar, Duygu Selcen, & Andrew G. Engel. (2005). Sporadic late onset nemaline myopathy. Neurology. 65(8). 1158–1164. 89 indexed citations
20.
Meÿer, Michael A., Carlos A. David, & Nizar Chahin. (2000). Palatal Myoclonus Secondary to Vertebral Artery Compression of the Inferior Olive. Journal of Neuroimaging. 10(4). 221–223. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026